FLUVIRUCINS A1, A2, B1, B2, B3, B4 AND B5, NEW ANTIBIOTICS ACTIVE AGAINST INFLUENZA A VIRUS I. PRODUCTION, ISOLATION, CHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES

Five unidentified actinomycete strains produced a series of novel antiviral antibiotics which have a unique 2, 6-dialkyl-10-ethyl-3(or 9)-hydroxy-13-tridecanelactam nucleus substituted with 3-amino-3, 6-dideoxy-L-talose or 3-amino-3, 6-dideoxy-L-mannose(L-mycosamine). The antibiotic components exhib...

Full description

Saved in:
Bibliographic Details
Published inJournal of antibiotics Vol. 44; no. 7; pp. 733 - 740
Main Authors NARUSE, NOBUAKI, TENMYO, OSAMU, KAWANO, KIMIO, TOMITA, KOJI, OHGUSA, NORIYUKI, MIYAKI, TAKEO, KONISHI, MASATAKA, OKI, TOSHIKAZU
Format Journal Article
LanguageEnglish
Published Tokyo JAPAN ANTIBIOTICS RESEARCH ASSOCIATION 1991
Japan Antibiotics Research Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Five unidentified actinomycete strains produced a series of novel antiviral antibiotics which have a unique 2, 6-dialkyl-10-ethyl-3(or 9)-hydroxy-13-tridecanelactam nucleus substituted with 3-amino-3, 6-dideoxy-L-talose or 3-amino-3, 6-dideoxy-L-mannose(L-mycosamine). The antibiotic components exhibited potent inhibitory activity against influenza virus type A Victoria strain infection in Madin Darby canine kidney cells by the cytopathic effect reduction assay.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.44.733